Apica Cardiovascular Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 8

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $35.1M

  • Investors
  • 1

Apica Cardiovascular General Information

Description

Developer of cardiovascular devices. The company develops transapical access and closure system that is designed to open and close the apex of a beating heart, in order to deliver large therapeutic devices into the inner chambers of the heart in a minimally invasive manner.

Contact Information

Website
www.apica.ie
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Unit 202, Business Innovation Centre
  • National University of Ireland, Upper New Castle Road
  • Galway
  • Ireland
+353 (091)
Primary Industry
Surgical Devices
Acquirer
Corporate Office
  • Unit 202, Business Innovation Centre
  • National University of Ireland, Upper New Castle Road
  • Galway
  • Ireland
+353 (091)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Apica Cardiovascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 02-Jul-2014 $35.1M Completed Product Development
2. Early Stage VC (Series A) 20-Jan-2011 Completed Startup
1. Seed Round 01-Jan-2009 Completed Startup
To view Apica Cardiovascular’s complete valuation and funding history, request access »

Apica Cardiovascular Patents

Apica Cardiovascular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2948104-A1 Systems and methods for percutaneous access, stabilization and closure of organs Active 25-Jan-2013
EP-2948104-A4 Systems and methods for percutaneous access, stabilization and closure of organs Active 25-Jan-2013
US-10028741-B2 Systems and methods for percutaneous access, stabilization and closure of organs Inactive 25-Jan-2013
US-11116542-B2 Systems and methods for percutaneous access, stabilization and closure of organs Active 25-Jan-2013
US-20150342602-A1 Systems and methods for percutaneous access, stabilization and closure of organs Active 25-Jan-2013 A61B17/0644
To view Apica Cardiovascular’s complete patent history, request access »

Apica Cardiovascular Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Apica Cardiovascular Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Enterprise Ireland Growth/Expansion Minority
Georgia Research Alliance Not-For-Profit Venture Capital Minority
Seroba Life Sciences Venture Capital Minority
Triventures Venture Capital Minority
To view Apica Cardiovascular’s complete investors history, request access »

Apica Cardiovascular FAQs

  • When was Apica Cardiovascular founded?

    Apica Cardiovascular was founded in 2009.

  • Where is Apica Cardiovascular headquartered?

    Apica Cardiovascular is headquartered in Galway, Ireland.

  • What is the size of Apica Cardiovascular?

    Apica Cardiovascular has 8 total employees.

  • What industry is Apica Cardiovascular in?

    Apica Cardiovascular’s primary industry is Surgical Devices.

  • Is Apica Cardiovascular a private or public company?

    Apica Cardiovascular is a Private company.

  • What is the current valuation of Apica Cardiovascular?

    The current valuation of Apica Cardiovascular is .

  • What is Apica Cardiovascular’s current revenue?

    The current revenue for Apica Cardiovascular is .

  • How much funding has Apica Cardiovascular raised over time?

    Apica Cardiovascular has raised $4.95M.

  • Who are Apica Cardiovascular’s investors?

    Enterprise Ireland, Georgia Research Alliance, Seroba Life Sciences, and Triventures have invested in Apica Cardiovascular.

  • When was Apica Cardiovascular acquired?

    Apica Cardiovascular was acquired on 02-Jul-2014.

  • Who acquired Apica Cardiovascular?

    Apica Cardiovascular was acquired by Thoratec.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process